JEMIN GAJIPARA: Open Payments
NPI 1922205939 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 53 payments from 15 companies in 2025. Trend: 2023 $3,347 · 2024 $2,161 · 2025 $1,232
Food & beverage: $1,153Travel & lodging: $79
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 10 | $213 |
| Collegium Pharmaceutical, Inc. | 13 | $199 |
| Curonix LLC | 4 | $154 |
| PROTEGA PHARMACEUTIALS INC | 6 | $138 |
| BIOTRONIK NRO, Inc. | 1 | $104 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $90 |
| Valinor Pharma, LLC | 4 | $82 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $59 |
| Boston Scientific Corporation | 2 | $41 |
| Medtronic, Inc. | 2 | $40 |
Products named: Prialt, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, ROXYBOND, XTAMPZA, Prospera, JOURNAVX, Nucynta, MOVANTIK.
Industry payments across TX — which companies pay providers there.
